Expect Stemline To Generate Acquisition Interest As SL-401 Approval Decision Nears

By: via Benzinga
Stemline Therapeutics Inc (NASDAQ: STML) shares were sliding Thursday after the company announced the completion of enrollment of ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.